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Abstract
Structural polymorphisms (L263P, M313V and S331P) in the third intracellular loop of the murine
histamine receptor H1 (H1R) are candidates for Bphs, a shared autoimmune disease locus in
experimental allergic encephalomyelitis (EAE) and experimental allergic orchitis. The P-V-P
haplotype is associated with increased disease susceptibility (H1RS) whereas the L-M-S haplotype
is associated with less severe disease (H1RR). Here we show that selective reexpression of the
H1RS allele in T cells fully complements EAE susceptibility and the production of disease associated
cytokines while selective reexpression of the H1RR allele does not. Mechanistically, we show that
the two H1R alleles exhibit differential cell surface expression and altered intracellular trafficking,
with the H1RR allele being retained within the endoplasmic reticulum (ER). Moreover, we show that
all three residues (L-M-S) comprising the H1RR haplotype are required for altered expression. These
data are the first to demonstrate that structural polymorphisms influencing cell surface expression of
a G-protein coupled receptor in T cells regulates immune functions and autoimmune disease
susceptibility.
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INTRODUCTION
Multiple sclerosis (MS) is the major demyelinating disease of the central nervous system (CNS)
in humans, affecting more than 2.5 million people worldwide (1). Both environmental and
genetic factors contribute to the immunopathologic etiology of the disease. A genetic
component in disease susceptibility is supported by the 20–30% concordance rate among
monozygotic twins and 3–5% for dizygotic twins. Compared to the general population, MS is
20–40 times more common in first degree relatives and there is no excess risk in adopted
relatives of patients with MS (2). Evidence of an environmental etiology in MS comes primarily
from migration studies and geographic distribution data. Migration studies indicate that
individuals moving from high-risk areas before puberty tend to adopt the lower risk of the
native population and vice versa (3). Thus, susceptibility to MS is likely the result of
environmental triggers acting on a susceptible genetic background at the population level.
Experimental allergic encephalomyelitis (EAE), the primary animal model of MS, is also a
genetically determined inflammatory disease of the CNS (4). EAE can be actively induced in
genetically susceptible animals by immunization with either whole spinal cord homogenate or
encephalitogenic proteins/peptides and adjuvants (5). EAE, like MS, is a complex polygenic
disease (6), with multiple genes exerting a modest effect, thus making it difficult to study the
contribution of individual loci to overall disease pathogenesis. However, reduction of complex
disease states into intermediate or subphenotypes that are under the control of a single locus
has the potential to facilitate mechanistic studies and gene identification (6). One such
phenotype associated with EAE is Bordetella pertussis toxin-induced histamine sensitization,
which is controlled by the single autosomal dominant locus known as Bphs (7). Previously,
we identified Hrh1/H1R as the gene underlying Bphs (7) and as a shared autoimmune disease
susceptibility gene in EAE (8) and experimental allergic orchitis (EAO) (9). H1R is a seven-
transmembrane spanning, G protein coupled receptor (GPCR). Generally, ligation of H1R with
histamine is believed to couple to second messenger signaling pathways via the activation of
the heterotrimeric Gαq/11 family of G proteins and leads to a variety of signaling cascades
depending on the cell type involved (10).
Compared to wild-type (WT) mice, H1R deficient (H1RKO) mice exhibit significantly reduced
EAE susceptibility (7). As a disease susceptibility gene, Hrh1/H1R can exert its effect in
multiple cell types involved in the disease process including endothelial cells, antigen
presenting cells and T cells. Moreover, H1R may function at critical check points during both
the induction and effector phases of the disease. In this regard, we recently demonstrated that
selective reexpression of the H1RS allele in T cells is sufficient to complement EAE in H1RKO
mice and that H1R signals are important during priming of naïve T cells rather than during the
effector phase of the disease (11).
Hrh1/H1R-susceptible (Hrh1S/H1RS) and –resistant (Hrh1R/H1RR) alleles differ by three
amino acids in their coding sequences (7). The H1RR haplotype possesses a L263, M313 and
S331 whereas the H1RS haplotype is characterized by P263, V313 and P331 (7). The mechanism
whereby these polymorphic residues influence EAE susceptibility is unknown but it was
hypothesized to be the result of differential coupling to second messenger signaling pathways,
because the three residues reside within the third intracytoplasmic domain associated with
Gαq/11 activation (12). Here we show that, unlike the H1RS allele (11), expression of the
H1RR allele in T cells does not complement EAE in H1RKO mice and that the polymorphic
residues of the H1RR allele affect intracellular trafficking and retention in the ER rather than
the inherent capacity to signal. Moreover, we show that all three residues (L-M-S) comprising
the H1RR haplotype are required for altered cell surface expression. These data are the first to
demonstrate that structural polymorphisms influencing differential cell surface expression of
a GPCR in T cells can regulate immune functions and susceptibility to autoimmune disease.
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MATERIALS AND METHODS
Mice
C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME). B6.129P-
Hrh1tm1Wat (H1RKO) (13) mice were maintained in the animal facility at the University of
Vermont (Burlington, VT). The experimental procedures used in this study were approved by
the Animal Care and Use Committee of the University of Vermont.
For transgenic mouse generation, the HA-H1RS or HA-H1RR constructs were made by deleting
the methionine of the Bphs-susceptible H1R allele from SJL/J and Bphs-resistant C3H/HeJ
mice, respectively (7), and adding an HA tag at the N-terminus using TOPO cloning vector
(Invitrogen, Carlsbad, CA). The HA-H1R was then subcloned downstream of the distal lck
promoter (14). The linear DNA fragment containing the distal lck promoter, the HA-H1R gene
and the human growth hormone (hGH) intron and polyadenylation signal was injected directly
into fertilized C57BL/6J eggs at the University of Vermont transgenic/knockout facility. Mice
were screened by DNA slot blot testing using a BamHI–SacI 0.5 kb fragment from the hGH
gene as a probe. Two founders were generated for both the H1RS and H1RR alleles and each
was crossed to H1RKO mice to establish transgenic mouse lines on the H1RKO background
(H1RKO-TgS1 and H1RKO-TgS2 and H1RKO-TgR1 and H1RKO-TgR2 mice). Mice from
the H1RKO-TgS1 line expressed the transgene at comparable levels to the two lines expressing
the H1RR allele, so it was used in all the experiments in this study.
Cytokine production
For cytokine analysis spleen and lymph nodes were obtained from mice immunized ten days
earlier with either MOG35–55-CFA plus PTX or 2× MOG35–55-CFA model, single cell
suspensions prepared at a concentration of 1 × 106 cells/ml in RPMI medium and stimulated
with 50 μg/ml of MOG35–55. Cell culture supernatants were recovered at 72 h and cytokine
levels measured by ELISA using anti-IFN-γ, anti-IL-4 and anti-IL17 mAbs and their
corresponding biotinylated mAbs (BD Pharmingen, San Diego, CA). TNF-α ELISA kit was
from (BD Pharmingen, San Diego, CA).
Proliferation Assays
Mice were immunized with the 2× MOG35–55-CFA protocol: single cell suspensions were
prepared at 2.5 × 105 cells/well in RPMI medium and stimulated in a 96 well plate with different
concentrations (0, 2, 10 and 50 μg/ml) of MOG35–55 for 72 h and proliferation was determined
by [3H]-thymidine incorporation during the last 18 h of culture.
Cell surface expression studies
The pEGZ-HA vector plasmid was a generous gift from Dr. Ingolf Berberich (University of
Wurzburg, Wurzburg, Germany). Two restriction sites, BamHI and EcoRI were inserted into
H1RS or H1RR cDNA by PCR and cloned such that the second codon is in-frame with the HA
tag of pEGZ generating an HA-H1R fusion protein. pEGZ is a bicistronic system with IRES-
EGFP. EGFP served as a marker for transfected cells.
HEK293T cells were plated at 1.25 × 106 cells/plate and cultured in DMEM-F12 containing
10% FBS. When the cells were about 50–80% confluent, they were transfected with 5 μg of
pEGZ-HA-H1RS, pEGZ-HA-H1RR or the empty pEGZ vector using calcium phosphate
method. After 16–24 h, cells were scraped off the plate by rigorous pipetting with 1% Calf
serum in PBS and stained with anti-HA mAb conjugated to PE (Miltenyi Biotech, Auburn,
CA) according to the manufacturer’s guidelines. Cells were analyzed by Flow cytometry using
FACSAria instrument (BD Pharmingen, San Diego, CA) and the data were further analyzed
using FlowJo flow cytometry analysis software (Tree star Inc, Ashland, OR).
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Confocal microscopy
HEK293T cells were transfected with pEGA-HA-H1RS, pEGZ-HA-H1RR or empty pEGZ
control vector (5 μg total DNA) using the calcium phosphate method. Cells were fixed,
permeabilized and stained using an anti-HA mAb (Cell Signaling Technologies, Danvers, MA)
followed by an incubation with Alexa-568 anti-mouse antibody (Molecular Probes, Eugene,
Oregon). TOPRO-3 nuclear stain (Molecular Probes, Eugene, Oregon) was used as a nuclear
marker. For non-permeabilized cells, the transfected HEK293T cells were stained with the
anti-HA mAb and were then fixed. Cells were examined by confocal microscopy using Zeiss
LSM 510 META Confocal Laser Scanning Imaging System (Carl Ziess Microimaging Inc,
Thronwood, NY).
Cell lysates and Western blotting
Whole-cell lysates were prepared from HEK293T cells transfected with various pEGZ
constructs in Triton lysis buffer and were then separated via sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes
as described previously (11). Anti-HA mAb (Abcam Inc. Cambridge, MA) was used as primary
antibody. Anti-actin (Santa Cruz Biotechnology, Santa Cruz, CA) was used as a loading
control.
[3H]mepyramine binding studies
[3H]mepyramine binding studies were conducted as described (15) and were used to measure
expression levels of H1R variants and the H1RS-Gαq/11 and H1RR-Gαq/11 fusion proteins.
[35S]GTPγS binding Assay
[35S]GTPγS binding experiments to assess the capacity of H1R variants to cause activation of
Gαq/11 were initiated by the addition of cell membranes containing 50 fmols of H1R variant
constructs to assay buffer (20mM HEPES (pH 7.4), 3mM MgCl2, 100mM NaCl, 1μM GDP,
0.2mM ascorbic acid, and 100nCi [35S]GTPγS) containing 100μM histamine. Non-specific
binding was determined in the above condition with the addition of 100μM GTPγS. Reactions
were incubated for 15 min at 30° C and were terminated by the addition of 500μl of ice-cold
buffer containing 20mM HEPES (pH 7.4), 3mM MgCl2, 100mM NaCl and 0.2mM ascorbic
acid. The samples were centrifuged at 16,000 × g for 10 min at 4° C. The resulting pellets were
re-suspended in solubilization buffer (100mM Tris, 200mM NaCl, 1mM EDTA, and 1.25%
Nonidet P-40) plus 0.2% SDS. Samples were precleared with Pansorbin for 1 h, followed by
immunoprecipitation with a C-terminal anti- Gαq/Gα11 antiserum (16). Finally, the
immunocomplexes were washed with solubilization buffer and bound [35S]GTPγS was
estimated by liquid scintillation-spectrometry.
Site directed mutagenesis
pEGZ-HA-H1RS was used as template to generate single H1RS mutants with each of the
polymorphic residues replaced with the corresponding residue of the H1RR allele using the
Quickchange (Strategene) site directed mutagenesis kit, according to the manufacturer’s
guidelines. The forward primers used for the mutagenesis were: for P263L 5′-
GGGGGTCCAGAAGAGGCCGTCAAGAGACCCTACTGG-3′, for V312M 5′-
CATGCAGACACAGCCTGTGCCTGAGGGAGATGCCAGG-3′, for P330S 5′-
CCAGACCTTGAGCCAGCCCAAAATGGATGAGCAGAGC-3′. The reverse primers were
the complementary sequences of these primers. The altered nucleotides are shown in bold and
underlined. The mutants were sequence confirmed and were used as template for the generation
of different combinations of double H1RS mutants.
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Conventional and Quantitative Real-Time Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted from CD4 T cells using RNeasy RNA isolation reagent (Qiagen,
Valencia, CA) as recommended by the manufacturer. cDNA generated from 1 μg total RNA
was used in conventional and quantitative real-time RT-PCR as described earlier (11).
Induction and Evaluation of EAE
Mice were immunized for the induction of EAE using either the MOG35–55-complete Freund’s
adjuvant (CFA) double-inoculation (2× MOG35–55-CFA) (17) or the MOG35–55-CFA plus
PTX single-inoculation (MOG35–55-CFA plus PTX) protocols (18). For the 2× MOG35–55-
CFA induction protocol mice are injected subcutaneously with an emulsion of 100 μg of
MOG35–55 and an equal volume of CFA containing 200 μg of Mycobacterium tuberculosis
H37RA (Difco Laboratories, Detroit, MI) in the posterior right and left flank; one week later
all mice were similarly injected at two sites on the right and left flank anterior of the initial
injection sites. Animals immunized using the MOG35–55-CFA plus PTX single-inoculation
protocol received an emulsion of 200 μg MOG35–55 and equal volume of CFA containing 200
μg of Mycobacterium tuberculosis H37RA by subcutaneous injections distributed equally in
the posterior right and left flank and scruff of the neck. Immediately thereafter, each animal
received 200 ng PTX (List Biological Laboratories, Campbell, CA) by intravenous injection.
Mice were scored daily starting at day 5 post-injection as previously described (18). Clinical
quantitative trait variables including disease incidence and mean day of onset (DO), cumulative
disease score (CDS), number of days affected (DA), overall severity index (SI) and the peak
score (PS) were generated as previously described (17).
Statistical analysis
Statistical analyses, as detailed in the figure legends, were performed using GraphPad Prism
4 software (GraphPad software Inc, San Diego, CA). A P value of 0.05 or less was considered
significant.
RESULTS
Expression of H1RR does not complement EAE in H1R deficient mice
Using transgenic complementation, we recently showed that expression of the H1RS allele only
in T cells of H1RKO mice was sufficient to restore EAE severity to WT levels in these mice
(11). To understand if the H1RR allele would also complement EAE in H1RKO mice, we
generated transgenic mice expressing the N-terminus hemagglutinin (HA)-tagged H1RR allele
under the control of the distal lck promoter, which drives expression in peripheral T cells
(14). The transgenic founders were generated directly on the C57BL/6J background and were
crossed to H1RKO mice to obtain H1RKO mice expressing the H1RR allele selectively in T
cells. The expression of the transgene in CD4 T cells was assessed by RT-PCR using transgene-
specific primers (Fig. 1a) and by real time RT-PCR using primers that recognize H1R (Fig.
1b). The two established lines of H1RR (H1RKO-TgR1 and H1RKO-TgR2) expressed the
transgene mRNA at levels comparable to one of the H1RS allele transgenic mice (H1RKO-
TgS) that we reported previously (11).
We then examined the susceptibility of these transgenic mice to myelin oligodendrocyte
glycoprotein peptide 35–55 (MOG35–55) induced EAE. We used two protocols to induce
disease, one using MOG35–55 plus complete Freund’s adjuvant (CFA) and pertussis toxin
(PTX) (MOG35–55-CFA plus PTX) (Fig. 1c) and the other using two injections of
MOG35–55 plus CFA (2× MOG35–55-CFA) (Fig. 1d), which does not use PTX as an ancillary
adjuvant. Regression analysis revealed that the clinical disease courses elicited by both
induction protocols fit a Sigmoidal curve and that the clinical course of disease in two
Noubade et al. Page 5
J Immunol. Author manuscript; available in PMC 2009 June 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
independent lines of H1RKO–TgR mice was not different from that in H1RKO mice. However,
as reported previously (11), the clinical course of EAE in H1RKO-TgS mice was significantly
more severe than that of H1RKO mice and was equivalent to the disease course observed in
WT mice. These results indicate that, unlike the H1RS allele, expression of the H1RR allele by
H1RKO T cells does not complement EAE susceptibility.
An analysis of EAE-associated clinical quantitative trait variables from the two transgenic
cohorts revealed that the mean day of onset (DO), cumulative disease score (CDS), overall
severity index (SI) and the peak score (PS) were significantly different among the strains
immunized with either MOG35–55-CFA plus PTX or 2× MOG35–55-CFA (Table 1). Post hoc
multiple comparisons of each trait variable revealed that H1RKO-TgS mice were equivalent
to WT mice while H1RKO-TgR mice were equivalent to H1RKO mice. Furthermore, for each
trait, H1RKO-TgS and WT mice were significantly greater than H1RKO-TgR and H1RKO
mice.
We next analyzed the ex vivo MOG35–55 specific proliferative response of spleen and draining
lymph node (DLN) cells from mice immunized with 2× MOG35–55-CFA. Significant
differences in proliferative responses were not detected among WT, H1RKO, H1RKO-TgS
and H1RKO-TgR mice (data not shown). Since MOG35–55-stimulated splenocytes from
immunized-H1RKO mice exhibit an immune deviation from Th1 to Th2 response in ex vivo
recall assays (7), we analyzed cytokine production by MOG35–55-stimulated spleen and DLN
cells from mice immunized with both EAE-induction protocols. With the classical
MOG35–55-CFA plus PTX protocol, as we observed previously (11), antigen-stimulated spleen
and DLN cells from H1RKO-TgS mice produced significantly greater amounts of IFN-γ
compared to H1RKO mice and at levels comparable to WT mice (Fig. 2a). In contrast, the
levels of IFN-γ produced by antigen-stimulated spleen and DLN cells from the two lines of
H1RKO-TgR mice were equivalent to those produced by H1RKO mice. Similarly, antigen-
stimulated spleen and DLN cells from H1RKO-TgS mice produced IL-4 at levels comparable
to WT mice while those from H1RKO-TgR mice were similar to H1RKO mice (Fig. 2b).
Similar results for IFN-γ (Fig. 2c) and IL-4 (Fig. 2e) were observed for 2× MOG35–55-CFA
immunized mice.
Because IL-17 is considered to be an important effector cytokine in EAE (19), we examined
IL-17 production by spleen and DLN cells following ex vivo stimulation with MOG35–55. IL-17
production by WT, H1RKO, H1RKO-TgS and H1RKO-TgR mice immunized with
MOG35–55-CFA and PTX was not significantly different (Fig. 2c) among strains. In contrast,
IL-17 production by MOG35–55 stimulated spleen and DLN cells from animals immunized
with 2× MOG35–55-CFA differed significantly among the strains (Fig. 2f). Compared to WT
mice, H1RKO mice produced significantly less IL-17, indicating that H1R signaling regulates
IL-17 production by T cells. Moreover, production of IL-17 by H1RKO-TgS mice was not
significantly different from WT mice and IL-17 production by H1RKO-TgR mice was not
significantly different from H1RKO mice (Fig. 2f). Taken together, like EAE, H1RR expression
in H1RKO T cells does not complement cytokine production by these cells.
H1R alleles activate Gαq and Gα11 equally well in vitro
The above results suggest that, in contrast to the H1RS allele, the H1RR allele is not functional.
To understand the mechanism by which the polymorphic residues of the H1RS and H1RR alleles
influence H1R function, we examined the predicted structural location for the three residues
within H1R. The three polymorphic residues reside within the third intracytoplasmic loop of
H1R (Fig 3a), which is the region frequently associated with recruitment and activation of
downstream G proteins (12). We, therefore, examined whether the polymorphic residues
distinguishing the H1RS and H1RR alleles might result in significant alterations in G protein
activation. Since H1R is normally coupled to Gαq and/or Gα11 proteins, we generated fusion
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proteins of the two H1R alleles with both Gαq and Gα11 by linking in-frame the N-terminus of
Gαq/11 with the C-terminal tail of H1RR or H1RS.
HEK293 cells were transfected with the H1RS-Gαq/11 or H1RR-Gαq/11 fusion proteins, lysed
and membrane fractions prepared from these cells. These were used initially to measure the
levels of expression of each construct via the specific binding of the H1R antagonist [3H]
mepyramine. There were no differences in the levels of specific binding of [3H]mepyramine
between the various constructs, indicating that the polymorphisms did not alter total protein
expression. Also, the binding affinity of [3H]mepyramine was not different between the two
alleles (Fig 3b). To study their differential capacity to activate Gαq and Gα11, membrane
amounts containing exactly the same number of copies of each construct were employed in
[35S]GTPγS binding assays. A maximally effective concentration of histamine stimulated
binding of [35S]GTP S equally to Gαq or Gα11 when each G protein was linked to either the
H1RS or H1RR variants (Fig. 3c, Fig. 3d). The dose-response curves to histamine indicated that
the potency of histamine is equivalent for each receptor variant (data not shown). These data
indicate that the H1RS and H1RR alleles can activate these G proteins equally well and that the
phenotypic difference associated with the H1R alleles is not inherently a function of differential
capability to activate Gαq or Gα11.
H1R alleles are differentially expressed on the cell surface
Specific mutations in the signaling domain of several GPCRs (e.g. vasopressin V2 receptor,
rhodopsin) can interfere with their cell surface expression and are associated with disease
(20). To determine if the polymorphisms in H1R influence cell surface expression of the
receptor, HA-H1RS or HA-H1RR expression vectors were used to transfect HEK293T cells.
The expression of these receptors at the cell surface was then examined by Flow cytometric
analysis using an anti-HA mAb. HA-H1RS was expressed at higher levels than HA-H1RR (Fig.
4a). The number of H1RS-positive cells (Fig. 4b) and the mean florescence intensity of H1RS
were considerably higher than those of H1RR, (Fig. 4c) indicating that the two H1R alleles are
differentially expressed on the cell surface. We observed similar results when the H1RS and
H1RR constructs were transfected into 721.221 B cells (data not shown).
In parallel, we examined the cell surface expression of H1RS and H1RR by confocal microscopy
using anti-HA mAb in cells stained prior to permeabilization. The results confirmed higher
expression of H1RS on the surface than H1RR (Fig. 4d). However, Western blot analysis of
H1RS and H1RR expression in lysates of transfected HEK293T cells showed no difference in
the amount of total protein present (Fig. 4e). Taken together, these data indicate that the
polymorphic residues associated with the H1RS and H1RR haplotypes result in differential
translocation of the receptor to the cell surface.
H1RR is retained in the endoplasmic reticulum
The Western blot results described above (Fig. 4e) suggest that the H1RS and H1RR alleles are
expressed at similar levels but that the H1RR allele is largely retained in intracellular
compartments instead of being trafficked to the cell surface. To investigate this possibility,
HEK293T cells were transfected with HA-H1RS or HA-H1RR constructs. After 24 h cells were
fixed, permeabilized, stained with anti-HA mAb and observed by confocal microscopy. A
predominantly plasma membrane staining pattern was observed for the H1RS allele (Fig. 5a).
In contrast, a large fraction of the H1RR allele appeared to localize intracellularly (Fig. 5b)
indicating that H1RR is retained in the intracellular compartments and fails to traffic efficiently
to the cell surface. The network-like intracellular distribution of H1RR throughout the cell (Fig.
5b, right panel) resembled that of endoplasmic reticulum (ER). Therefore, to determine if the
H1RR allele is retained in this compartment, we transiently co-transfected HEK293T cells with
H1RS or H1RR constructs and a plasmid expressing the dsRed fluorescent protein that targets
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the ER. Co-localization of the two proteins was examined by confocal microscopy following
staining the cells for HA-H1R. The majority of H1RR was again expressed intracellularly and
co-localized with the dsRed protein, while minimal colocalization of H1RS with the ER-
targeted dsRed protein was observed (Fig. 5b). Using LSM5 image browser software, we
quantified the number of pixels that express both dsRed protein and HA-H1R in multiple cells
that were imaged under exactly the same settings. The results showed a significant difference
in the co-localization of the H1RS and H1RR alleles in ER (Fig. 5c), suggesting that the
H1RR L-M-S haplotype leads to its sequestration and retention in ER.
Retention of H1RR in the ER requires the L-M-S haplotype
To understand which of the three amino acids comprising the H1RR L-M-S haplotype is
responsible for the observed differential cell surface expression of the allele we generated
single H1RS mutants, replacing each of the H1RS haplotype associated residues with the
corresponding H1RR allele (P263L, V312M, and P330S), by site directed mutagenesis.
HEK293T cells were transfected with H1RS, H1RR and each of the three H1RS mutant
constructs. Cells were stained with anti-HA mAb, without permeabilization, and cell surface
expression of H1R analyzed by Flow- cytometry. Each of the single H1RS mutants was
expressed at higher levels on the cell surface than the H1RR allele (Fig. 6a) with the levels
comparable to those observed with the H1RS allele. This indicates that the presence of a single
H1RR polymorphism is not sufficient to induce its intracellular retention. We also generated
double mutants of the H1RS allele wherein we replaced two residues of the H1RS haplotype
with the corresponding residues of the H1RR allele (P263L and V312M, P263L and P330S,
V312M and P330S). Similar to the single H1RS mutants, the double H1RS mutants were
expressed on the cell surface at levels comparable to the H1RS and at significantly higher levels
than the H1RR allele (Fig. 6b). We observed similar results in 721.221 B cells following
transient transfection with H1RS, H1RS mutants and H1RR constructs (data not shown).
Furthermore, when HEK293T cells were co-transfected with double H1RS mutants and the
dsRed plasmid, each of the mutants showed a typical plasma membrane expression pattern
with very little co-localization with the ER-targeted dsRed protein (Fig. 6c). Quantification of
the number of pixels expressing dsRed- protein and HA-H1R confirmed that each of the double
H1RS mutants behaved like H1RS and only H1RR was retained in ER (Fig. 6d), confirming the
flow cytometry data that all the polymorphic residues are required for differential cell surface
expression of the H1R alleles. Taken together, these data indicate that all three residues of the
H1RR L-M-S haplotype are required for its intracellular sequestration. Interestingly, we
sequenced the H1R alleles from more than 100 different inbred laboratory and wild-derived
mouse strains and did not identify any recombinant haplotypes suggesting that the two alleles
are evolutionarily conserved and may have been selected functionally (data not shown).
DISCUSSION
To date, Hrh1/H1R is the only murine EAE and EAO susceptibility gene that has been
positionally cloned (7). In this study, using transgenic mouse models, we show that
polymorphic variants in H1R regulate cytokine production by T cells thereby influencing
susceptibility to EAE. Furthermore, using HEK293T cells, we show that the polymorphisms
in H1R affect its functions by modulating cell surface expression rather than inherently altering
the capacity of the receptor to generate intracellular signals.
Hrh1/H1R has long been implicated in EAE susceptibility (7,8). As H1R is widely expressed
(10), this suggested that it might act in different cell types and at multiple checkpoints. We
recently showed, however, that H1R expression in T cells is sufficient to complement EAE
severity in H1RKO mice. In this study, we show that the polymorphic residues of the H1RR
allele interfere with its ability to complement EAE in H1RKO mice. This is in accordance with
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genetic complementation studies in F1 hybrids between H1RKO and strains of mice expressing
the H1RS or H1RR alleles. Susceptibility to histamine sensitivity could be restored in F1 hybrids
of H1RKO and SJL/J, 129X1/SvJ or C57BL/6J that express H1RS allele but not in F1 hybrids
between H1RKO and C3H/HeJ or CBA/J mice that express H1RR (7).
Hrh1/H1R also controls delayed type hypersensitivity (DTH) responses when PTX is used as
an adjuvant. The DTH response is mediated by CD4 T cells that produce large amounts of IFN-
γ (21–23). Using C3H. BphsS congenic mice expressing the H1RS allele from SJL/J mice on
the resistant C3H/HeJ background, Gao et al., (24) showed that polymorphisms in H1R regulate
ovalbumin-specific DTH response elicited in mice immunized with ovalbumin in CFA and
PTX, indicating that the polymorphisms in H1R regulate IFNγ production by CD4 T cells. This
study confirms the role of H1R polymorphisms in regulating IFN-γ production by these cells.
Further, the complementation of IFN-γ production by splenocytes immunized using the 2×
MOG35–55 model suggests that H1R regulation of IFNγ production by T cells does not require
PTX.
Recently, IL-17-producing Th17 CD4 T cells have been considered more pathogenic in EAE
(19). We show here, for the first time, that H1R signaling regulates IL-17 production and that
H1R polymorphisms influence IL-17 production by T cells. However, it is noteworthy that we
did not observe differences in IL-17 production between WT and H1RKO mice immunized
with MOG35–55-CFA plus PTX, nor in Th17 cells differentiated in vitro in the presence of
excessive amounts of IL-6. PTX promotes the generation of Th17 cells, by inducing IL-6
production (25). Thus, it is possible that immunization with PTX (in vivo) or addition of
exogenous IL-6 (in vitro) enables CD4 T cells to overcome the absence of H1R signals required
for the optimal IL-6 production and generation of Th17 cells. Even though we observed
significant differences in IL-17 production by spleen and DLN cells from transgenic mice
selectively expressing either H1RS or H1RR in T cells, we believe, based on in vitro
differentiation data, that the H1R regulation of IL-6 and IL-17 is independent of H1R signals
in T cells. In this regard, compared to WT macrophages H1RKO macrophages produce
significantly less IL-6 (unpublished data) and treatment of lung parenchymal macrophages
with H1R blockers results in decreased IL-6 production (26). Further studies are being carried
out to elucidate the role of H1R in the generation of Th17 CD4 T cells.
GPCRs, in spite of the diversity of their polypeptide sequences, as a family retain enough
structural information to allow them to be properly folded in the ER and adopt their highly
conserved seven transmembrane confirmation (27). Several studies have identified critical
residues and motifs important in many of the functions of GPCRs including ligand binding, G
protein coupling, internalization, downregulation and intracellular trafficking (28). However,
the three polymorphic residues distinguishing the H1RS and H1RR alleles are located in the
third intracytoplasmic loop and do not constitute any known motif. Even though the exact
PXXP motif is not present, it is worth noting that two of the three polymorphic residues
associated with the H1RS haplotype are prolines, and that proline rich-motifs are known to
mediate protein-protein interactions with Src homology SH3 domains (29). In this regard,
polymorphic residues containing polyproline motifs in the third intracytoplasmic loop of the
dopamine D4 receptor and β1-adrenergic receptor have been shown to interact with multiple
SH3 domain-containing proteins (30) and affect the trafficking of these receptors. However,
at this point, we do not have any evidence to suggest that H1R interacts with any of the known
SH3 domain-containing proteins or that such interactions differ between H1RS and H1RR
alleles. Future studies will address this issue.
GPCRs interact with numerous proteins that play a role in their cellular trafficking (12). H1R
has an unusually long third intracytoplasmic loop, suggesting that the polymorphic residues
may result in improper folding of the receptor to a non-native conformation in ER, which is
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then recognized by the quality control machinery of molecular chaperones and excluded from
ER export. Several chaperone proteins [such as Nina (31,32), ODR-4 (33,34) and a variety of
receptor activity modifying proteins (RAMPs) (35,36)] that support the trafficking of a range
of GPCRs to their target site have been identified. Therefore, it is possible that polymorphic
residue-induced misfolding of H1RR could hinder its interaction with an essential chaperone
thereby affecting its trafficking.
Proper cell surface expression of GPCRs is required to access the requisite ligands and signal
transduction machinery (12). The functional importance of proper GPCR localization is
emphasized by several human diseases that result from receptor mutation and mislocalization,
including X-linked nephogenic diabetes, retinitis pigmentosa and hypogonadotrophic
hypogonadism, which result from intracellular accumulation of mutant V2 vasopressin
receptor, rhodopsin and gonadotropin releasing hormone receptor, respectively (20). In fact,
mutations that lead to intracellular accumulation comprise the largest class of mutations in
GPCRs that result in human diseases (12). Accordingly, our results are the first to demonstrate
that structural polymorphisms influencing differential trafficking and cell surface expression
of a GPCR in T cells can regulate immune functions and susceptibility to autoimmune disease.
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Figure 1.
Transgenic expression of the H1RR allele in H1RKO T cells fails to complement EAE in
H1RKO mice. H1R transgene expression was analyzed by (a) RT-PCR and (b) quantitative
RT-PCR in CD4 T cells from H1RKO mice and transgenic mice expressing the H1RS or
H1RR allele that were crossed with H1RKO mice (H1RKO-TgS, H1RKO-TgR1 and H1RKO-
TgR2). H1RKO-TgR1 and H1RKO-TgR2 represent two independent lines. (c) Clinical EAE
in WT (n = 19), H1RKO (n = 56), H1RKO-TgS (n = 24), and H1RKO-TgR (n = 17) mice that
were immunized with MOG35–55-CFA plus PTX. Mice were scored daily starting at D5.
Regression analysis revealed that the disease course elicited fits a Sigmoidal curve and that the
clinical disease course of the animals was significantly different among the strains. The clinical
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disease courses of WT and H1RKO-TgS mice were both significantly more severe than those
of H1RKO-TgR and H1RKO mice (P < 0.0001 for all comparisons). (d) WT (n = 18), H1RKO
(n = 33), H1RKO-TgS (n = 23), and H1RKO-TgR (n = 14) mice were immunized with 2×
MOG35–55-CFA. EAE severity was significantly different among the strains. The clinical
disease courses of WT and H1RKO-TgS mice were both significantly more severe than those
of H1RKO-TgR and H1RKO mice (P < 0.0001 for all comparisons).
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Figure 2.
Transgenic expression of H1RR in H1RKO T cells fails to complement cytokine production
by H1RKO mice. (a–c) Spleen and draining lymph node (DLN) cells were isolated from
MOG35–55-CFA plus PTX-immunized WT, H1RKO, H1RKO-TgS and H1RKO-TgR mice 10
days post immunization and stimulated with 50 μg/ml of MOG35–55 for 72h (n=4–8 mice per
group). Supernatants were collected and analyzed for the production of IFN-γ (a), IL-4 (b) and
IL-17 (c). Significance of differences in cytokine production were assessed by Kruskal-Wallis
statistical analysis followed by Dunn’s post-hoc multiple comparisons (Kruskal-Wallis statistic
= 25.73; p < 0.0001 for IFNγ, Kruskal-Wallis statistic = 31.34; p < 0.0001 for IL-4, Kruskal-
Wallis statistic = 0.514; p > 0.5 for IL-17. * p< 0.05 ** p<0.01 and *** p<0.001). (d-f) Spleen
and DLN cells from 2× MOG35–55-CFA immunized mice were collected on day 10 post
immunization and were activated with 50μg/ml of MOG35–55 for 72h, supernatants were
collected and analyzed for IFN-γ (d), IL-4 (e) and IL-17 (f) by ELISA in triplicate. Significance
of differences in cytokine production were assessed by Kruskal-Wallis statistical analysis
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followed by Dunn’s post-hoc multiple comparisons (Kruskal-Wallis statistic = 52.23; p <
0.0001 for IFNγ, Kruskal-Wallis statistic = 23.88; p < 0.0001 for IL-4, Kruskal-Wallis statistic
= 35.22; p < 0.0001 for IL-17. * p< 0.05 ** p<0.01 and *** p<0.001). Data are presented as
the mean ± SEM and are representative of two independent experiments.
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Figure 3.
H1RS and H1RR activate Gαq/11 G proteins equally well. (a) The amino acid sequence of the
mouse histamine receptor H1 is displayed with differences between the H1RR allele (Red) and
the H1RS allele (Yellow) highlighted. Each of the sites of variation is within the long, third
intracellular loop. (b) Saturation [3H]mepyramine binding studies were performed on
membranes of HEK293T cells transfected to express a H1R−Gαq fusion protein (left hand side
H1RR, right hand side H1RS). Non-specific binding was determined in the same manner but
with the additional presence of 1μM mianserin. Data are presented as the mean ± SEM. These
studies provided quantitation of construct expression levels. (c and d) membranes containing
50 fmol of H1RS or H1RR linked to either Gαq (c) or Gα11 (d) were used in [35S]GTPγS binding
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studies conducted in the absence (basal, open bars) or presence (histamine, filled bars) of 100
μM histamine to assess the capability of the two variants to activate the G proteins. H1RS and
H1RR were equi-effective in causing activation of each G protein. Representative data from
four independent experiments are shown.
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Figure 4.
H1RS and H1RR alleles are differentially expressed on the cell surface. (a) HEK293T cells
were transfected with empty pEGZ, pEGZ-HA-H1RS or pEGZ-HA-H1RR plasmids. Cells were
collected 16–24h later without trypisinization, stained with anti-HA mAb and analyzed by
Flow cytometry. The thin line represents cells transfected with empty pEGZ whereas the thick
line represents cells transfected with HA-H1RS and the filled area represents cells transfected
with HA-H1RR. (b & c) HEK293T cells were analyzed as in (a) and the percentage (b) and
the mean florescence intensity (MFI) of anti-HA on H1RS positive cells (c) were determined.
(d) HEK293T cells transfected with HA-H1RS or HA-H1RR plasmids and 24 h later cells were
stained with anti-HA mAb (red) without permeabilization. Cells were visualized by confocal
microscopy. GFP (green) is shown as a marker of transfected cells. (e) HEK293T cells were
transfected as in (a), whole cell lysates prepared and analyzed by Western blotting using anti-
HA mAb. Actin is shown as loading control. Representative data from three independent
experiments are shown.
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Figure 5.
H1RR is retained in the endoplasmic reticulum. (a) HEK293T cells were transfected with HA-
H1RS or HA-H1RR plasmids. 24h later, cells were fixed, permeabilized, stained with anti-HA
mAb (red) and TOPRO-3 nuclear stain (blue) and visualized by confocal microscopy. (b)
HEK293T cells were co-transfected with pdsRed plasmid that express ER targeted florescent
dsRed protein (red) and HA-H1RS or HAH1RR. 24h later cells were fixed, permeabilized,
stained with anti-HA mAb (green) and the co-localization of HA-H1R with dsRed was
visualized by confocal microscopy. Yellow color represents the co-localization of red and
green colors. (c) Quantification of HA-H1R co-localization with dsRed protein. Using Zeiss
LSM 510 META Confocal imaging software, the numbers of pixels expressing both colors
were determined (n ≥ 26) and the data is presented as the average of number of pixels that co-
express dsRed and HA-H1R. Error bars represent SEM. Data were analyzed using Mann-
Whitney statistical test (Mann-Whitney U = 133.0 **** p<0.00001).
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Figure 6.
ER retention of the H1RR allele requires the L-M-S haplotype. (a) HEK293T cells were
transfected with empty control, single HA-H1RS mutants or HA-H1RR plasmids. Cells were
collected 16–24 h later without trypisinization, stained with anti-HA mAb and analyzed by
flow cytometry. Cells transfected with HA-H1RS are shown as positive controls in the far-right
panel. The thin line represents cells transfected with empty pEGZ whereas the thick line
represents cells transfected with HA-H1RS and the filled area represents cells transfected with
HA-H1RR. (b) HEK293T cells were analyzed as in (a) and the mean florescence intensity of
anti-HA on H1RS positive cells was determined. The data presented is the average of triplicate
transfections. (c) HEK293T cells were co-transfected with pdsRed plasmid that express ER
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targeted dsRed protein (red) and HA-H1RS, mutants of HA-H1RS or HA-H1RR. 24h later, cells
were fixed, permeabilized, stained with anti-HA mAb (green) and the co-localization of HA-
H1R with dsRed (red) was visualized by confocal microscopy. Yellow color represents the co-
localization of red and green colors. (d) Quantification of HA-H1R co-localization with dsRed
protein. Using Zeiss LSM 510 META Confocal imaging software the number of pixels
expressing both the colors was determined in a number of cells (n ≥ 16) and the data is presented
as the average of number of pixels that co-express dsRed and HA-H1R. Error bars indicate
SEM.
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